NYSE:EME
NYSE:EMEConstruction

Is EMCOR Group (EME) Still Attractively Priced After Strong Multi‑Year Share Price Gains?

If you are wondering whether EMCOR Group's current share price lines up with its underlying value, you are not alone. The stock most recently closed at US$698.69, with returns of 8.1% over 7 days, 14.3% over 30 days, 9.4% year to date, 38.2% over 1 year, 384.8% over 3 years and a very large gain over 5 years. Recent coverage has focused on EMCOR Group's position as a major player in electrical and mechanical construction, as well as facilities services across the US. This attention helps...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Is Zions Bancorporation (ZION) Pricing Look Attractive After Recent Share Price Softness

If you are wondering whether Zions Bancorporation National Association is priced attractively right now, you are in the right place to make sense of what the current share price might be offering you. The stock last closed at US$59.62, with a 1% decline over the past week and a 0.5% slip over the last month, while the 1 year return sits at 6.2% and the 5 year return at 47.0%. Recent price moves are drawing attention back to how regional banks are being valued, with investors weighing up...
NYSE:CARR
NYSE:CARRBuilding

Assessing Carrier Global (CARR) Valuation After Insider And Institutional Buying Before Earnings

Carrier Global (CARR) is back in focus as its Chairman and CEO increases personal shareholdings and institutions like PineStone Asset Management add exposure, just as the company approaches its upcoming quarterly earnings announcement. See our latest analysis for Carrier Global. At a share price of US$56.19, Carrier Global has seen a 4.5% 30 day share price return and a 5% year to date share price return. Its 1 year total shareholder return of an 18.5% decline contrasts with 3 and 5 year...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

How REDEMPLO’s China Approval and New Capital Raises Will Impact Arrowhead Pharmaceuticals (ARWR) Investors

Arrowhead Pharmaceuticals recently reported interim Phase 1/2a results for its obesity candidates ARO-INHBE and ARO-ALK7 and, through its partnership structure, secured a third major regulatory approval for REDEMPLO (plozasiran) for familial chylomicronemia syndrome, with the latest authorization granted by China’s National Medical Products Administration. Alongside these clinical and regulatory milestones, Arrowhead raised fresh capital via a roughly US$200 million follow-on equity offering...
NYSE:BXMT
NYSE:BXMTMortgage REITs

A Look At Blackstone Mortgage Trust’s (BXMT) Valuation After Securing Paramount As First Tenant At Sunset Pier 94 Studios

Blackstone Mortgage Trust (BXMT) is in focus after affiliate Blackstone Real Estate, together with its partners, secured Paramount Television Studios as the first tenant at Manhattan’s new Sunset Pier 94 Studios ahead of its opening. See our latest analysis for Blackstone Mortgage Trust. The Paramount lease lands at a time when Blackstone Mortgage Trust’s share price has been relatively steady at around $19.62, with a 90 day share price return of 9.73% and a 1 year total shareholder return of...
NYSE:BLX
NYSE:BLXDiversified Financial

Will Bladex’s Tech-Driven Trade Platform Pivot Reshape Banco Latinoamericano de Comercio Exterior’s (BLX) Core Narrative?

Banco Latinoamericano de Comercio Exterior (Bladex) recently announced it had hosted a virtual investor day on March 24, 2026, where leadership reviewed progress on its 2022–2026 plan and outlined its roadmap through 2030. A key theme from the event was Bladex’s push to evolve from a specialized trade lender into a broader transactional trade banking platform for Latin America, emphasizing scalable, technology-enabled, fee-based services. We’ll now examine how Bladex’s shift toward a...
NYSE:AA
NYSE:AAMetals and Mining

Is It Too Late To Reassess Alcoa (AA) After Its Recent 1-Year Share Price Surge

If you are wondering whether Alcoa's current share price still offers value after a strong run, this article walks through what the numbers are saying about the stock today. At a last close of US$60.07, the stock has seen a 5.7% decline over the past week, a 17.2% gain over the last 30 days, a 6.2% gain year to date and a 53.9% gain over the past year, with a 22.1% gain over 3 years and a very large 5 year return. Recent market commentary around Alcoa has focused on its role as a major...
NYSE:SMG
NYSE:SMGChemicals

Assessing Scotts Miracle-Gro (SMG) Valuation As Recent Momentum Meets Longer Term Shareholder Declines

Why Scotts Miracle-Gro stock is drawing fresh attention Scotts Miracle-Gro (SMG) is back on many investors’ watchlists after recent trading showed mixed returns, with gains over the past month and past 3 months contrasted by a 1 year total return decline. See our latest analysis for Scotts Miracle-Gro. The recent 30 day share price return of 8.44% and 90 day share price return of 16.67% suggest momentum has been improving, even though the 1 year total shareholder return shows a 5.27% decline...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Assessing NextDecade (NEXT) Valuation After New Rio Grande LNG Contract Commentary

NextDecade (NEXT) is back in focus after fresh commentary on its Rio Grande LNG project, which is framed as a potential long term supplier to Europe as the region reduces reliance on Russian gas. See our latest analysis for NextDecade. The latest commentary around Rio Grande LNG and its long term European role arrives after a sharp 1 day share price return of 4.13% and a 7 day share price return of 8.18%. However, the 1 year total shareholder return of a 41.87% decline shows momentum has been...
NasdaqGM:MDB
NasdaqGM:MDBIT

Is It Time To Reassess MongoDB (MDB) After Its Strong Three Year Share Price Run

If you are wondering whether MongoDB's current share price lines up with its long term potential, you are not alone. This article will focus squarely on what the numbers say about value. The stock last closed at US$399.76, with returns of 2.0% decline over 7 days, 7.2% decline over 30 days, flat performance year to date, and 57.9% over 1 year and 102.0% over 3 years. This naturally raises questions about what is already baked into the price. Recent headlines have focused on MongoDB's role as...
NYSE:BG
NYSE:BGFood

Assessing Bunge Global (BG) Valuation As Earnings Slide And Cash Concerns Cloud Long-Term Growth

Recent commentary around Bunge Global (BG) has focused on a 3.7% annual sales decline over three years, a 19% yearly drop in earnings per share, and concerns about shrinking cash reserves. See our latest analysis for Bunge Global. Despite the earnings pressure, the recent 30 day share price return of 17.86% and 90 day share price return of 10.86% suggest improving momentum. The 1 year total shareholder return of 40.28% points to a much stronger result for investors who stayed invested through...
NYSE:CMC
NYSE:CMCMetals and Mining

Is Commercial Metals (CMC) Now At An Attractive Price After Strong Five Year Share Gains

If you are wondering whether Commercial Metals' recent share price puts it on sale or at a premium, you are not alone. This article will focus on what the current price might imply about value. The stock recently closed at US$74.42, with returns of 2.7% over 7 days, 7.1% over 30 days, 3.7% year to date, 49.0% over 1 year and 48.5% over 3 years, while the 5 year return sits at 270.6%. These moves have kept investor attention on Commercial Metals as part of broader interest in materials and...
NYSE:ELV
NYSE:ELVHealthcare

Is Elevance Health (ELV) Pricing Reflect Its DCF And P/E Valuation Gap Today

If you are wondering whether Elevance Health is offering good value right now, it helps to step back and look at how its current share price lines up with its fundamentals. The stock most recently closed at US$374.87, with returns of 0.5% over 7 days, 10.0% over 30 days, 5.8% year to date, a 0.8% decline over 1 year, an 18.2% decline over 3 years, and 27.7% over 5 years. Together, these figures give you a mixed picture of shorter term momentum and longer term results. Recent news coverage...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

BOK Financial (BOKF) Net Interest Margin Strengthens Bullish Narratives In FY 2025 Results

BOK Financial (BOKF) just closed out FY 2025 with fourth quarter revenue of US$589.6 million and basic EPS of US$2.91, backed by net income of US$177.3 million. Over the past year, revenue has moved from US$523.1 million in Q4 2024 to US$589.6 million in Q4 2025, while trailing twelve month EPS sits at US$9.23. With a net interest margin of 2.98% and a cost to income ratio of 64.89% in the latest quarter, the focus this season is on how efficiently the bank is turning that top line into...
NYSE:FDS
NYSE:FDSCapital Markets

Is It Time To Reassess FactSet (FDS) After Its 36.9% One-Year Share Price Decline?

If you are wondering whether FactSet Research Systems at around US$288.60 is priced fairly or not, you are not alone. This article is designed to help you make sense of that question. The stock has been fairly flat over the last month with a 0.0% 30-day return. However, the 1-year return of a 36.9% decline and the 5-year return of a 5.5% decline may have some investors reassessing its growth potential and risk. Recent share price moves sit against a backdrop of ongoing attention on financial...
NYSE:HRB
NYSE:HRBConsumer Services

Is H&R Block’s (HRB) Free Tax Pro Review Trial Redefining Its Hybrid Moat In Tax Prep?

In early January 2026, H&R Block announced that new clients using its paid DIY online tax products can access Tax Pro Review at no additional cost through February 15, adding professional review to its digital filing experience amid growing tax code complexity tied to measures like the One Big Beautiful Bill Act. This move highlights H&R Block’s effort to close the gap between pure DIY and fully assisted filing, using its 10,000-office network and digital tools such as AI Tax Assist to offer...
NYSE:LUMN
NYSE:LUMNTelecom

Why Lumen Technologies (LUMN) Is Up 6.8% After New AI Fiber Deals And Debt Progress

In recent months, Lumen Technologies reported quarterly results showing better liquidity and lower debt, while also securing fiber and cloud-focused deals with Microsoft, IBM, and Google Cloud to expand its AI-oriented network and services. An important implication is Lumen’s own projection of returning to revenue and earnings growth by 2029, tied to its multi‑billion‑dollar fiber build‑out and ongoing debt restructuring. We’ll now examine how Lumen’s AI-focused fiber expansion with...
NYSE:BKU
NYSE:BKUBanks

A Look At BankUnited (BKU) Valuation After Raymond James Initiates Coverage With Outperform Rating

BankUnited (BKU) drew fresh attention after Raymond James initiated coverage with an Outperform rating, coinciding with a 3.1% intraday move and a new 52 week high that has sharpened investor focus on the stock. See our latest analysis for BankUnited. The Raymond James initiation has come after a strong run, with a 90 day share price return of 27.52% and a 1 year total shareholder return of 22.23%. This is signaling momentum that investors are treating as increasingly backed by improving...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Does Renewed Analyst Support For ON's EV And Automation Pivot Change The Bull Case For ON?

In recent days, several brokerage firms have reiterated positive views on ON Semiconductor, highlighting its progress in intelligent power and sensing solutions across automotive, industrial, and AI data center markets. Analysts emphasized the company’s pivot toward emerging applications such as electric and autonomous vehicles, industrial automation, and renewable energy, signaling confidence in the reshaped business mix despite industry margin pressures. We’ll now examine how this...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

The Bull Case For Nasdaq (NDAQ) Could Change Following New Options Expirations And AI Data Push – Learn Why

In January 2026, Juniper Square announced the next phase of its partnership with Nasdaq, embedding Nasdaq’s eVestment institutional investor intelligence platform into Juniper Square’s AI CRM, while Nasdaq also received SEC approval to introduce Monday and Wednesday stock options expirations for selected major stocks. Together, these moves highlight Nasdaq’s push deeper into data and technology services while expanding trading flexibility, potentially increasing its importance to both...
NYSE:FVRR
NYSE:FVRRProfessional Services

A Look At Fiverr International (FVRR) Valuation After Recent Share Price Weakness And Growth Expectations

Fiverr International (FVRR) has drawn fresh attention after a 13.3% share price decline over the past month, even as the broader market advanced, as expectations build for higher EPS and revenue in the upcoming quarter. See our latest analysis for Fiverr International. At a latest share price of US$16.57, Fiverr International’s recent weakness has not been limited to the past month, with a 30 day share price return of 16.82% and a year to date share price return of 15.80% alongside a 1 year...
NYSE:ITGR
NYSE:ITGRMedical Equipment

What Integer Holdings (ITGR)'s Guidance Cut and Lawsuits Mean For Shareholders

In October 2025, Integer Holdings cut its full-year 2025 sales guidance after slower-than-expected market adoption of several electrophysiology products, and since then multiple law firms have launched securities class actions alleging the company overstated its competitive position and long-term growth prospects. At the same time, Integer is continuing to showcase innovations in neuromodulation and miniaturized implantable devices, underscoring a tension between its technical capabilities...
NasdaqGM:HIFS
NasdaqGM:HIFSBanks

Hingham Institution For Savings FY 2025 Net Interest Margin Rebound Challenges Bearish Narratives

How Hingham Institution for Savings' FY 2025 Numbers Set Up the Earnings Story Hingham Institution for Savings (HIFS) closed FY 2025 with fourth quarter total revenue of US$34.5 million and basic EPS of US$9.49, while trailing twelve month revenue reached US$102.8 million and EPS came in at US$25.01, setting a clear earnings marker for investors to work from. Over the past year, revenue has moved from US$65.5 million and EPS of US$12.95 on a trailing basis in Q4 2024 to US$102.8 million and...
NYSE:BRO
NYSE:BROInsurance

Is Brown & Brown (BRO) Still Attractive After Recent Share Price Weakness?

If you are wondering whether Brown & Brown, at around US$80 per share, still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are actually saying about the stock. The share price is at US$80.01 after a 0.8% decline over the last 7 days and a 0.2% decline over the last 30 days. The year-to-date return sits at 3.1% and the 1-year return is a 23.7% decline, compared with 32.2% over 3 years and 74.2% over 5 years. Recent news around...